Heart transplantation: An answer for end-stage heart failure

Critical Care Nursing Clinics of North America

Volumn 15, Issue 4, 2003, Pages 489-494

  Smith, Lanna ^a   Farroni, Jennifer ^a   Baillie, Barbara Ryan ^a   Haynes, Hwajoo ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; FORECASTING; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; REVIEW; SURVIVAL RATE; UNITED STATES; ARTIFICIAL HEART; DEVICE; DIAGNOSTIC TEST; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GRAFT REJECTION; HEART FAILURE; HYPERLIPIDEMIA; HYPERTENSION; IMPLANTATION; INFECTION; LABORATORY TEST; MEDICAL ASSESSMENT; MEDICAL RESEARCH; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; OBESITY; ORGAN DONOR; OSTEOPOROSIS; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; QUALITY OF LIFE; SURGICAL TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; XENOTRANSPLANTATION;

FORECASTING; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; IMMUNOSUPPRESSION; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; UNITED STATES; WAITING LISTS;

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TSUKUBAENOLIDE;

EID: 1442285451     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00087-4     Document Type: Review

References (28)

1. What is congestive heart failure? Available at: http://www.mayoclinic. com/findinformation/diseasesandconditions. Accessed June 13, 2002
2. Cooper D.K. Profiles in cardiology: Christiaan Neethling Barnard. Clin Cardiol. 24(7):2001;527-528
3. Cooper D.K. Christiaan Barnard and his contributions to heart transplantation. J Heart Lung Transplant. 20(6):2001;599-610
4. Keon W.J. Heart transplantation in perspective. J Card Surg. 14(2):1999;147-151
5. Shumay N.E. Forty years of thoracic transplantation at Stanford. Transplant Proc. 31:1999;46
6. Cooley D.A. A brief history of heart transplants and mechanical assist devices. Frazier O.H., Macris M., Radovancevic B. Support and replacement of the failing heart. 1996;5-15 Lippincott-Raven, Philadelphia
7. Young J.B., Hass G.J., Starling R.C. Managing heart failure with transplantation, ventricular assist devices, and cardiomyoplasty. Poole-Wilson P.A., Colucci W.S., Massie B.M., et al. Heart failure: scientific principles and clinical practice. 1997;827-851 Churchill Livingston, New York
8. Caves P.K., Billingham M.E., Schulz W.P., et al. Transvenous biopsy from canine orthotopic heart allografts. Am Heart J. 85:1973;525-530
9. Annual report of the US scientific registry of transplant recipients and the organ procurement and transplantation network. Transplant data 1989-1998. 2001;UNOS, Richmond (VA). Available at: http://www.unos.org. Accessed May 7, 2002
10. Young J.B. Cardiac transplantation: three decades of experience define our challenge. Transplant Proc. 30(5):1998;1885-1888
11. Koerner M., Durand J.B., Lafuente J.A., et al. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr Opin Cardiol. 15:2000;178-182
12. Rourke T., Droogan M., Ohler L. Heart transplantation: state of the art. AACN Clin Issues. 10(2):1999;185-201
13. Cupples S., Spruill L. Evaluation criteria for the pretransplant patient. Crit Care Nurs Clin North Am. 12(1):2000;35-47
14. Miller L. Listing criteria for cardiac transplantation. Transplantation. 66(7):1998;947-951
15. Steinman T., Becker B., Frost A., et al. Guidelines for the referral and management of patients eligible for solidorgan transplant. Transplantation. 71(9):2001;1189-1204
16. Borkon A., Muehlebach G., Jones P., et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 18(7):1999;668-674
17. Hobson J. How the system functions: the roles of the United Network of Organ Sharing, the Organ Procurement and Transplantation Network, and the organ procurement organization in heart transplant. Crit Care Nurs Clin North Am. 12(1):2000;11-21
18. United Network of Organ Sharing Online Organ distribution policy. Available at: http://www.unos.org/pdf_shared/policy_policies03_7.pdf. Accessed June 24, 2002
19. Bush W. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. AACN Clin Issues. 10(2):1999;253-269
20. Augustine S. Long-term management related to immunosuppression, complications, and psychosocial adjustments. Crit Care Nurs Clin North Am. 12(1):2000;69-77
21. Gummert J.F., Ikonen T., Morris R.E. Newer immunosuppressive drugs. J Am Soc Nephrol. 10(6):1999;1-27
22. Snell G.I., Levvey B.J., Chin W., et al. Rescue therapy: a role for sirolimus in lung and heart transplant recipients. Transplant Proc. 33:2001;1084-1085
23. Chillcott S.R., Atkins P.J., Adamson R.M. Left ventricular assist as a viable alternative for cardiac transplantation. Crit Care Nurs Q. 20(4):1998;64-79
24. Building a better heart. The Franklin Institute Online. Available at: http://sln.fi.edu. Accessed April 17, 2002
25. Platt J.L. Physiologic barriers to xenotransplantation. Transplant Proc. 32:2000;1547-1548
26. Frati G., Frati P., Mussi L., et al. Medical and ethical issues in xenotransplantation: the opinion of the public, patients, and transplant candidates in Italy. Transplant Proc. 33(1-2):2001;1184-1185
27. Hunt S.A. Current status of heart transplantation. JAMA. 280(19):1998;1692-1697
28. Orosz C.G. Transplantation without immunosuppression: what the future may hold. Cleve Clin J Med. 66(7):1999;395-396